Taiwan Extracellular Vesicle Medical Promotion Association

台灣胞外體醫療發展協會

navigation.contact

Kimera® Labs Receives FDA Phase I/IIa IND Approval For Its MSC Exosomes Human Study

Latest News

##Academic Research #Clinical Laboratory

Kimera® Labs Receives FDA Phase I/IIa IND Approval For Its MSC Exosomes Human Study

Related Articles

2025 Bio-Food Association Members' Conference－ Chen Shih-Chung: Three major databases will become the "three arrow" of biotech. Regenerative medicine methods will be complete and drive international expansion.

Taiwan Bioindustry Development Association

2026 台灣細胞醫療協會年會 / 2026 TACT Annual Meeting 「科技智醫AI啟動再生」

誠摯邀請參與盛會 2026 台灣細胞醫療協會年會 / 2026 TACT Annual Meeting 「科技智醫AI啟動再生」日期/Date：115年...

打造生醫版「台積電」？再生醫療雙法正式上路台灣如何靠 ICT 優勢切入全球「半導體式」醫藥分工？

台灣醫界聯盟基金會執行長林世嘉。/Photo Credit:林世嘉研議了多年的《再生醫療法》與《再生醫療製劑條例》（簡稱為「再生醫療雙法」）於今年起正式落地...